Abbvie (ABBV) PT Lowered to $87 at BofA/Merrill Lynch
Tweet
Share
E-mail
Get Alerts ABBV Hot Sheet
Price: $250.82 +0.83%
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
28 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
BofA/Merrill Lynch analyst Jason Gerberry lowered the price target on Abbvie (NYSE: ABBV) to $87.00 (from $95.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Abbvie (ABBV) to Outperform
- The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
